- Antineoplastic drugs makes a new breakthrough 2014-09-05
The drug JY023 being developed by Biotech Pharma has made a new breakthrough in treating many neoplastic diseases.
- AbMax develops key Ebola protein 2014-09-05
AbMax has taken the lead in China in expressing the Ebola GP1 protein with 293 eukaryocytes, and has discovered three linear surface loci of proprietary intellectual property rights.
- Zhifei Lvzhu vaccines gain GMP recognition 2014-09-05
A combined vaccine independently developed by Zhifei Lvzhu Biopharmaceutical have passed site inspection and review and have been recognized to conform to the Good Manufacturing Practice for Pharmaceutical Products.
- A pioneer of new drug research and development 2014-09-05
Tao Xiumei led her team to begin from scratch, making earth-shaking changes for her enterprise.
- Two workshops in Yizhuang obtains GMP certificate 2014-09-05
The Yizhuang Plant of Tiantan Biological Products announced that the OPV workshop and MMR workshop have received GMP certification, which guarantees the production of the company.
- Mob/Fox Industrial Park begins operation 2014-09-05
On August 31, the last department moved into the Mob/Fox headquarters, a new industrial park at the junction of Kechuang 12th Street and Paiganqu West Road in the development area.